RE: Investor Presentation 8th April30 Mar 2021 13:43
To be fair, POLX has passed all the three trail phases so provided they win the FDA approval, this stock will fly, no doubt. Most of the NHS pulmonary imaging are invasive and costly. I know they are targeting the USA market but if the get the nod from FDA, I don't see why EMA or MHRA or any other health authority would say no to them specially when their tech would be so much beneficial to the entire medical industry, specially when people are suffering from lung problems due to Covid.
Justin Waite was right about one thing though, polx has all the potential to become a billion dollar company. Let's wait and see then.
GLA